These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 32159371)
1. The dual phosphodiesterase 3/4 inhibitor RPL554 stimulates rare class III and IV CFTR mutants. Turner MJ; Luo Y; Thomas DY; Hanrahan JW Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L908-L920. PubMed ID: 32159371 [TBL] [Abstract][Full Text] [Related]
2. The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia. Turner MJ; Matthes E; Billet A; Ferguson AJ; Thomas DY; Randell SH; Ostrowski LE; Abbott-Banner K; Hanrahan JW Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(1):L59-70. PubMed ID: 26545902 [TBL] [Abstract][Full Text] [Related]
3. The Phosphodiesterase Inhibitor Ensifentrine Reduces Production of Proinflammatory Mediators in Well Differentiated Bronchial Epithelial Cells by Inhibiting PDE4. Turner MJ; Dauletbaev N; Lands LC; Hanrahan JW J Pharmacol Exp Ther; 2020 Dec; 375(3):414-429. PubMed ID: 33012706 [TBL] [Abstract][Full Text] [Related]
4. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors. Liu S; Veilleux A; Zhang L; Young A; Kwok E; Laliberté F; Chung C; Tota MR; Dubé D; Friesen RW; Huang Z J Pharmacol Exp Ther; 2005 Aug; 314(2):846-54. PubMed ID: 15901792 [TBL] [Abstract][Full Text] [Related]
5. Modulation of cAMP metabolism for CFTR potentiation in human airway epithelial cells. Nguyen JP; Bianca M; Huff RD; Tiessen N; Inman MD; Hirota JA Sci Rep; 2021 Jan; 11(1):904. PubMed ID: 33441643 [TBL] [Abstract][Full Text] [Related]
6. Novel amino-carbonitrile-pyrazole identified in a small molecule screen activates wild-type and ΔF508 cystic fibrosis transmembrane conductance regulator in the absence of a cAMP agonist. Namkung W; Park J; Seo Y; Verkman AS Mol Pharmacol; 2013 Sep; 84(3):384-92. PubMed ID: 23788656 [TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke activates CFTR through ROS-stimulated cAMP signaling in human bronchial epithelial cells. Wong FH; AbuArish A; Matthes E; Turner MJ; Greene LE; Cloutier A; Robert R; Thomas DY; Cosa G; Cantin AM; Hanrahan JW Am J Physiol Cell Physiol; 2018 Jan; 314(1):C118-C134. PubMed ID: 28978522 [TBL] [Abstract][Full Text] [Related]
8. Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone. Calzetta L; Page CP; Spina D; Cazzola M; Rogliani P; Facciolo F; Matera MG J Pharmacol Exp Ther; 2013 Sep; 346(3):414-23. PubMed ID: 23766543 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways. Calzetta L; Cazzola M; Page CP; Rogliani P; Facciolo F; Matera MG Pulm Pharmacol Ther; 2015 Jun; 32():15-23. PubMed ID: 25899618 [TBL] [Abstract][Full Text] [Related]
11. DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers. Rowe SM; Pyle LC; Jurkevante A; Varga K; Collawn J; Sloane PA; Woodworth B; Mazur M; Fulton J; Fan L; Li Y; Fortenberry J; Sorscher EJ; Clancy JP Pulm Pharmacol Ther; 2010 Aug; 23(4):268-78. PubMed ID: 20226262 [TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis. Lambert JA; Raju SV; Tang LP; McNicholas CM; Li Y; Courville CA; Farris RF; Coricor GE; Smoot LH; Mazur MM; Dransfield MT; Bolger GB; Rowe SM Am J Respir Cell Mol Biol; 2014 Mar; 50(3):549-58. PubMed ID: 24106801 [TBL] [Abstract][Full Text] [Related]
13. Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770. Gentzsch M; Ren HY; Houck SA; Quinney NL; Cholon DM; Sopha P; Chaudhry IG; Das J; Dokholyan NV; Randell SH; Cyr DM Am J Physiol Lung Cell Mol Physiol; 2016 Sep; 311(3):L550-9. PubMed ID: 27402691 [TBL] [Abstract][Full Text] [Related]
14. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508. deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183 [TBL] [Abstract][Full Text] [Related]
15. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel. Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400 [TBL] [Abstract][Full Text] [Related]
16. Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis. Awatade NT; Uliyakina I; Farinha CM; Clarke LA; Mendes K; Solé A; Pastor J; Ramos MM; Amaral MD EBioMedicine; 2015; 2(2):147-53. PubMed ID: 26137539 [TBL] [Abstract][Full Text] [Related]
17. Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast. Latorre RV; Calicchia M; Bigliardi M; Conti J; Kleinfelder K; Melotti P; Sorio C Respir Investig; 2024 May; 62(3):455-461. PubMed ID: 38547757 [TBL] [Abstract][Full Text] [Related]